La Libra, Facebook's digital currency, announced for 2021 in reduced format

The launch of Facebook's digital currency, Libra , could take place in 2021. The project may benefit from favorable factors in the global economy, but regulators will have to be convinced first.  Facebook could launch Libra, its digital currency in 2021, we learn from the British media Financial Times, which quotes people close to the process. The product is expected to arrive in a limited version, after the project has met with great aversion from regulators, including in the United States, the country where the headquarters of the social media management company are located. The stakeholder association behind this digital currency project is now planning to launch a single version of Libra that will itself be pegged to the dollar, at the rate of one unit of US currency for each Facebook digital currency . “The other forms of currencies will be deployed at a later stage,” the FT source added. The exact launch date will depend on when the project

Coronavirus: The strategic importance of the national drug industries

The Coronavirus crisis has strained global economies, social balance, and health systems at large. In this context, the dominant ideologies for the past twenty years, which consisted of concentrating drug production units in certain areas in the name of economies of scale for large groups, are beginning to be challenged. Never before has the need to build national drug industries capable of ensuring the health sovereignty of countries, or even of coherent economic zones, become so pressing. Morocco will not escape this new rule. It is a question here not only of doing what is relevant in a changing economic environment, but also, in the case of Morocco, of supporting the ambitious path laid down by the Head of State, His Majesty Mohammed VI, who demonstrates world-renowned leadership in managing the Covid-19 crisis.

Coronavirus: The strategic importance of the national drug industries

In Morocco, defending a strong national pharmaceutical industry has been a battle waged for several decades by national players in the drug industry. Grouped within the Moroccan Association of the Pharmaceutical Industry (AMIP), the leading professional association in the sector, the main national players are indeed campaigning for the country to build a strong and sustainable pharmaceutical industry, guaranteeing the security of citizens and health independence.

Committed for 35 years to strengthen the national pharmaceutical policy and support the development of the sector, AMIP places the improvement of the accessibility of Moroccans to innovative and generic drugs, at the heart of its concerns and encourages the promotion of local production in order to protect citizens from possible shortages or major health crises.

Covid-19 reveals the limits of globalization

A true case study, the Covid-19 pandemic revealed in the most sinister way, the limits of globalization and foreign over-dependence, especially in China, in terms of access to raw materials and treatment. With more than 154,000 deaths in a few months, the coronavirus has put the whole planet on maximum emergency, and has demonstrated the decisive role occupied by national pharmaceutical production in this race for care.

More than a simple component of the national economy, the drug is becoming today more than ever, a central strategic axis of the industrial and health policy of the country, which it is necessary to support and secure.

Convinced of the importance of collective mobilization of professionals in the sector, AMIP and its 29 operators implemented, from the start of this health crisis, a series of strict preventive measures. In order to respond effectively to the high demand for certain treatments and hygiene products, and to avoid shortages of essential drugs, the production and distribution of several million boxes is permanently ensured for the benefit of the Ministry of Health. , the main hospitals and health establishments in the kingdom as well as wholesalers and pharmacies spread throughout the territory.



Strong commitment from national pharmaceutical players

In order to maintain their activity, our members are committed to strengthening the security measures already in place, in particular by instituting the wearing of a mandatory mask and the systematic taking of the temperature of employees at production sites, by encouraging telework for functions. which lend themselves to it, by disinfecting workspaces and vehicles, as well as ensuring compliance with safety distances.

Finally, in response to the Sovereign's appeal, the 29 members of AMIP contributed 55 million dirhams to the special solidarity fund initiated by King Mohammed VI for the management of the coronavirus. Strongly committed to the public authorities In the fight against Covid-19 disease, the 29 operators of AMIP also made substantial donations in kind, including large stocks of medicines and protective equipment.

Aware of the challenges posed by the coronavirus crisis, AMIP and its members are mobilizing and unreservedly committed alongside the Sovereign and the health authorities in order to effectively combat the spread of the virus and guarantee access to healthcare in better conditions for the whole population. As a continuation of this commitment, the Moroccan pharmaceutical manufacturers also want to help build African health independence, since Moroccan products have been distributed on the continent for several years, making this sector one of the most ripe to carry the Kingdom's export ambition in this area. In general, AMIP has adopted the leitmotif put forward by His Majesty Mohammed VI during the historic speech in Abidjan on February 14, 2014: "Africa must trust Africa"